Delivery Order SPE2DB22D3501-SPE2DB25FWF43
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,329.44 by the Defense Logistics Agency (DLA) for the supply of Imdelltra 10 mg vials. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 2, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, designated as SPE2DX and valued at...
- The Defense Logistics Agency awarded a $14,687.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Imdelltra 10 mg vials, with a completion date of June 9, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $10,805.30 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,730.40 by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child order under the company's larger indefinite delivery vehicle. The award was competitively awarded with no set-aside designation, and performance will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,740 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 18, 2025, with completion scheduled for June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was not set-aside and was competitively awarded, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- The Defense Logistics Agency awarded a $2,069.32 delivery order to AmerisourceBergen Drug Corp for Imdelltra 1 mg vials, a pharmaceutical product supporting federal medical procurement needs. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of October 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,116.16 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWF43Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,329.44 to AmerisourceBergen Drug Corp for Imdelltra 10 mg vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a ceiling value of $999,999,999.00 and runs through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain, delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of reliable pharmaceutical supply chains to federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 6/30/25 |